Pages that link to "Q34271693"
Jump to navigation
Jump to search
The following pages link to Absolute quantification of somatic DNA alterations in human cancer (Q34271693):
Displaying 50 items.
- Inferring clonal composition from multiple sections of a breast cancer (Q21145293) (← links)
- Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors (Q21183964) (← links)
- An extensive evaluation of read trimming effects on Illumina NGS data analysis (Q21559489) (← links)
- Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate (Q24273274) (← links)
- A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1 (Q24294219) (← links)
- A landscape of driver mutations in melanoma (Q24603357) (← links)
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer (Q24616117) (← links)
- Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine (Q26748603) (← links)
- Evaluation and consequences of heterogeneity in the circulating tumor cell compartment (Q26765357) (← links)
- Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials (Q26776394) (← links)
- Patterns of Chromosomal Aberrations in Solid Tumors (Q26786127) (← links)
- Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine (Q26825186) (← links)
- Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges (Q26864808) (← links)
- Bioinformatics for cancer immunology and immunotherapy (Q26864876) (← links)
- Breast cancer intra-tumor heterogeneity (Q27000086) (← links)
- Cancer evolution: mathematical models and computational inference (Q27002537) (← links)
- Emerging patterns of somatic mutations in cancer (Q27014126) (← links)
- Evolution of the cancer genome (Q27020991) (← links)
- Clonal evolution in hematological malignancies and therapeutic implications (Q27027655) (← links)
- Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer (Q27307642) (← links)
- SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution (Q27321859) (← links)
- Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities (Q27345462) (← links)
- SInC: an accurate and fast error-model based simulator for SNPs, Indels and CNVs coupled with a read generator for short-read sequence data (Q27496505) (← links)
- SF3B1 mutations in chronic lymphocytic leukemia (Q27852162) (← links)
- Comprehensive molecular characterization of clear cell renal cell carcinoma (Q27852374) (← links)
- Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity (Q27852678) (← links)
- Mutational landscape of aggressive cutaneous squamous cell carcinoma (Q27853082) (← links)
- Genomic Classification and Prognosis in Acute Myeloid Leukemia (Q27853389) (← links)
- Comprehensive molecular profiling of lung adenocarcinoma (Q28244995) (← links)
- Integrated genomic characterization of papillary thyroid carcinoma (Q28251986) (← links)
- Hypermutation in human cancer genomes: footprints and mechanisms (Q28255066) (← links)
- POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer (Q28260529) (← links)
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer (Q28268284) (← links)
- The somatic genomic landscape of glioblastoma (Q28300185) (← links)
- Discovery and saturation analysis of cancer genes across 21 tumour types (Q28305204) (← links)
- Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas (Q28305680) (← links)
- Karyotyping human and mouse cells using probes from single-sorted chromosomes and open source software (Q28364950) (← links)
- Statistical Methods in Integrative Genomics (Q28385219) (← links)
- Diet and esophageal disease (Q28391919) (← links)
- Transcriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53 (Q28552677) (← links)
- Statistical Inference in Hidden Markov Models Using k-Segment Constraints (Q28602739) (← links)
- Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis (Q28649475) (← links)
- Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas (Q28650140) (← links)
- Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution (Q28655705) (← links)
- The causes and consequences of genetic heterogeneity in cancer evolution (Q29615848) (← links)
- Implementing Genome-Driven Oncology (Q30235979) (← links)
- The challenges of tumor genetic diversity (Q30241056) (← links)
- Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening (Q30252065) (← links)
- SubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization (Q30410213) (← links)
- Unraveling the clonal hierarchy of somatic genomic aberrations. (Q30587156) (← links)